The Patent Portfolio Research Of The Human Gene

At the beginning of the 21 st century, with the completion of human genome project, the global after entering the post-genome era, gene technology is developing rapidly.If we want to take a place in the international community,we should have the advantage in terms of gene technology.At present, many developed countries in order to compete for the limited human genetic resources, multinational biotechnology companies through gene patent strategy to capture the global market.China is one of the main market of human gene technology,multinational biotechnology companies look at it.At present, for domestic enterprises, the market is smaller, and the protection of intellectual property rights is weaker.So the domestic enterprises should take some measures to improve their market competitiveness, such as completes the patent information analysis and make their own strategy to protect their patent.Human gene patent information analysis shows that the global human gene technology and market entered its maturity.it will develop to such technologies like gene mutation, genetic engineering and gene therapy technical fields in the future.On the market, the United States, Europe is the main patent application areas of human gene technology.Many biotechnology companies which have stronger market competitiveness and holds the leading technology were from the United States and Europe areas.Through the patent information analysis about some foreign institutions such as Roche, Johnson & Johnson, the university of California,we know Roche and Johnson & Johnson has began to build a global patent strategy about the human gene technology.It maintained a stable investment on research and have a study on many fields about the technology.They attaches great importance to the native market and also take into account other regions, while the United States is the first selection of these enterprise’s competition.In contrast,the university of California focused on the research and development about the technology,it’s the reason why the market competitiveness is weaker.For China, human gene patent information analysis shows that China have a vast market of gene technology,the amount of patent applications only behind to the United States.But the analysis also shows that the core patent not too much, and some research institutions who haven’t market competitiveness master the core technology.And then, the domestic patent application are limited to China, rarely has attention tothe protection of the international market.Compared with foreign core institutions,domestic institutions lack of advantages about market and technology.Domestic enterprises need to make their own strategy when they face the foreign institutions.Against the main problems that leading technology with the separation of the market,Domestic enterprises can learn from the united gene group ltd.They can obtain patent licenses from the research institutions who holding the core technology.As for industry, they should rely on production-study-research cooperation to promote technology innovation,with complementary advantages make industry get rapid development.In this way can we prevent multinational biotechnology company’s patent strategy, and break the barriers to foreign patents.